8 December, 2011
The bad drug lawsuit attorneys at AvandiaRecallNews.com no longer are accepting new Avandia cases. We continue to help families affected by Zoloft birth defects.
Our lawyers are accepting and aggressively litigating nationwide Zoloft Lawsuit claims to collect damages for Zoloft birth defects.
Call us now at 800-845-6913 or click this link for Zoloft Lawsuit Information.
Let us help you and your child recover the Zoloft birth defects compensation you deserve.
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Safety | Avandia Senate Report | Avandia Settlements | Avandia Side Effects | Avandia Warning | Congestive Heart Failure16 October, 2011
A federal judge presiding over Avandia litigation denied drug maker GlaxoSmithKline’s motion to dismiss 60 Avandia lawsuits on statute of limitations grounds. GSK attempted to convince the judge that the claims were filed too late. Continue reading Avandia statute of limitations ruling allows new lawsuits to proceed
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements | Avandia Side Effects6 April, 2011
A new Avandia study has reached a familiar conclusion: Avandia poses a higher risk of heart attack, congestive heart failure (CHF) and death compared to its rival diabetes drug, Actos. The new research confirms the findings of earlier Avandia heart risks studies. Continue reading Avandia heart attack, CHF and stroke risks higher, new study confirms
Category: Avandia Cardiovascular Risk | Avandia Lawsuit | Avandia News | Avandia Safety | Avandia Settlements | Avandia Side Effects17 January, 2011
Avandia drug company GlaxoSmithKline announced today that it will take a $3.4 billion legal charge against earnings in the fourth quarter 2011 to cover Avandia settlements and legal costs. GSK said it continues to receive new legal claims. Avandia lawsuit attorneys continue to file cases across the U.S. in 2011. Avandia settlements are being reached on stroke, congestive heart failure, and Avandia heart attack claims. Continue reading 2011 Avandia Settlements: GSK's $3.4 billion Avandia drug legal charge
Category: Avandia Cardiovascular Risk | Avandia News | Avandia Settlements19 November, 2010
Health Canada, the national drug regulatory agency, has put tight new restrictions on the use of Avandia (rosiglitazone), Avandamet (rosiglitazone and metformin) and Avandaryl (rosiglitazone and glimepiride).
To get a new Avandia prescription, diabetes patients will be required to sign an informed consent form confirming that they have read and understand consumer information about the drug’s heart-related risks and discussed with their physician other diabetes treatment options. In addition, A new boxed warning has been added to the package insert. Continue reading Canada puts new restrictions on diabetes drug Avandia
Category: Avandia Cardiovascular Risk | Avandia News | Avandia Side Effects | Avandia Warning | Congestive Heart Failure18 November, 2010
Since its FDA approval in 1999, Avandia heart attack, stroke, heart failure and heart related death side effects have led to safety alerts, black box warnings, and bad drug lawsuit settlements.
A timeline of events alerting diabetes patients, the FDA and Avandia lawsuit attorneys of the heart attack and other cardiovascular risks associated with the diabetes drug. Continue reading Avandia Timeline: Diabetes Drug Side Effects, FDA Warnings
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Senate Report | Avandia Side Effects15 October, 2010
A FDA Avandia news conference was held on September 23, 2010 to announce the FDA decision on Avandia and for FDA drug safety officials to take questions from the media.
The following is a complete transcript of the news conference. FDA Commissioner Margaret Hamburg, FDA Principal Deputy Commissioner Joshua Sharfstein and Janet Woodcock, Director of the Center for Drug Evaluation and Research at FDA all were in attendance. Continue reading FDA Avandia news conference: 2010 rosiglitazone restrictions
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Recall | Avandia Safety | Avandia Warning8 October, 2010
In May 2007, Cleveland Clinic cardiologist Dr. Steven Nissen published an Avandia study in the New England Journal of Medicine that would mark a turning point for the diabetes drug Avandia.
Dr. Nissen found that Avandia use was linked to a 43% increased risk of heart attack. and has been a vocal critic of Avandia ever since. Dr. Nissen reacts to the September 23, 2010 FDA Avandia restrictions. Continue reading FDA Avandia heart attack news, Avandia critic reacts to FDA
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Safety | Avandia Settlements | Avandia Warning25 September, 2010
FDA stops Avandia TIDE trial due to unjustified risk of stroke and cardiac events.
Act now to make you Avandia settlement claim. FDA drug safety experts concluded that the TIDE trial subjected participants to an unjustified risk of heart disease. All of the regulatory deadlines set by the FDA for completion of the trial have been rescinded. Continue reading FDA stops Avandia TIDE trial due to unjustified heart risks
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Safety28 August, 2010
A new study comparing heart side effects risks of rival diabetes drugs Avandia and Actos suggests both treatments carry similar risks of heart attack, acute heart failure and death.
Researchers at health insurance company WellPoint reviewed the claims records of over 29,000 diabetic clients who took either of the drugs between 2001 and 2005. The study was published on August 24, 2010 in the medical journal, “Circulation: Cardiovascular Quality and Outcomes.” Continue reading Avandia heart risks similar to Actos claims new study
Category: Avandia Cardiovascular Risk | Avandia Lawsuit | Avandia News | Avandia Safety | Avandia Side Effects